Drug intelligence / Profile preview

SpayVac

Development stage
Unknown
Lead developer
SpayVac-for-Wildlife
Modality
Vaccines & Immunotherapeutics, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intramuscular
01

Overview

SpayVac is a single-dose, long-acting immunocontraceptive vaccine used primarily for controlling fertility in wildlife, livestock, and companion animals. Its main active ingredient is porcine zona pellucida (pZP) or other zona pellucida antigens, delivered using a patented liposome-based delivery platform (such as VacciMax or DepoVax) that enhances immunogenicity and longevity by gradually releasing the antigen to the immune system[1][6][10]. After injection, SpayVac stimulates an antibody response against the zona pellucida membrane surrounding the egg, thereby blocking sperm binding and preventing fertilization. This immune response is robust, tissue-specific, and can last for multiple years without the need for booster shots[1][6][10]. Developed for use in feral horses, deer, seals, domestic cats, and aquaculture species, SpayVac represents a humane, non-surgical approach to animal population control, with applications currently under regulatory review for feral horses and deer[5][9][10].

Brand names
SpayVac
Other names
SpayVacSpayVac-pZPSpayVac VacciMaxSpayVac DepoVax
02

Targets

ZP (Zona pellucida glycoprotein)

Beyond the preview

Go deeper on SpayVac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpayVac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call